Bio-Rad Laboratories, Inc. (BIO.B)
NYSE: BIO.B · Real-Time Price · USD
387.50
0.00 (0.00%)
Oct 6, 2026, 1:00 PM EDT - Market open
Bio-Rad Laboratories Market Cap
Bio-Rad Laboratories has a market cap or net worth of $10.08 billion as of October 6, 2026. Its market cap has increased by 22.33% in one year.
Market Cap
10.08B
Enterprise Value
9.83B
1-Year Change
22.33%
Ranking
Category
Stock Price
$387.50
ChartMarket Cap Chart
Since October 7, 2021, Bio-Rad Laboratories's market cap has decreased from $21.89B to $10.08B, a decrease of -53.94%. That is a compound annual growth rate of -14.36%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 6, 2026 | 10.08B | 23.42% |
| Dec 31, 2025 | 8.17B | -11.01% |
| Dec 31, 2024 | 9.18B | -1.27% |
| Dec 29, 2023 | 9.30B | -25.52% |
| Dec 30, 2022 | 12.48B | -44.81% |
| Dec 31, 2021 | 22.62B | 3.33% |
| Oct 7, 2021 | 21.89B | - |
View and export this data all the way back to 2021. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| STERIS | 20.58B |
| Zimmer Biomet Holdings | 17.47B |
| 10x Genomics | 12.73B |
| Penumbra | 12.49B |
| Smith & Nephew | 11.17B |
| Globus Medical | 10.28B |
| Bio-Rad Laboratories | 10.16B |
| Bruker | 9.73B |